These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Cancer vaccines: pessimism in check. Mocellin S; Mandruzzato S; Bronte V; Marincola FM Nat Med; 2004 Dec; 10(12):1278-9; author reply 1279-80. PubMed ID: 15580242 [No Abstract] [Full Text] [Related]
26. An introduction to tumour immunology. James K Arch Immunol Ther Exp (Warsz); 1983; 31(6):795-808. PubMed ID: 6611141 [TBL] [Abstract][Full Text] [Related]
27. Current condition and prognosis of tumor immunotherapy: a second opinion. Mastrangelo MJ; Berd D; Maguire HC Cancer Treat Rep; 1984 Jan; 68(1):207-19. PubMed ID: 6362864 [No Abstract] [Full Text] [Related]
28. Human tumour-associated antigens: targets for monoclonal antibody-mediated cancer therapy. Reisfeld RA; Cheresh DA Cancer Surv; 1985; 4(1):271-90. PubMed ID: 3916082 [No Abstract] [Full Text] [Related]
29. Basic principles of the immune response and the immunologic inhibition of tumors. Vorlaender KO Allergol Immunopathol (Madr); 1973 Jul; 1(4):235-46. PubMed ID: 4794103 [No Abstract] [Full Text] [Related]
30. [Identification of cancer antigens of relevance for specific cancer immunotherapy]. van den Eynde B Bull Mem Acad R Med Belg; 2001; 156(10-12):548-55. PubMed ID: 12371273 [TBL] [Abstract][Full Text] [Related]
32. Effects of the tumor microenvironment on the efficacy of tumor immunotherapy. Neeson P; Paterson Y Immunol Invest; 2006; 35(3-4):359-94. PubMed ID: 16916758 [TBL] [Abstract][Full Text] [Related]
33. [Immunotherapy for cancer--modern immunologic strategies in oncology]. Halama N; Zoernig I; Jäger D Dtsch Med Wochenschr; 2008 Oct; 133(41):2105-8. PubMed ID: 18985564 [TBL] [Abstract][Full Text] [Related]
34. About human tumor antigens to be used in immunotherapy. Lucas S; Coulie PG Semin Immunol; 2008 Oct; 20(5):301-7. PubMed ID: 18395462 [TBL] [Abstract][Full Text] [Related]
35. Dendritic cells as vectors for immunotherapy of cancer. Paczesny S; Ueno H; Fay J; Banchereau J; Palucka AK Semin Cancer Biol; 2003 Dec; 13(6):439-47. PubMed ID: 15001163 [TBL] [Abstract][Full Text] [Related]
36. Tumour immunology: the end of the beginning. Hall JG Practitioner; 1982 Dec; 226(1374):2010-20. PubMed ID: 7170295 [No Abstract] [Full Text] [Related]
37. Immunology in tumor therapeutics: an overview. Barber HR Del Med J; 1980 Apr; 52(4):197-209. PubMed ID: 6153996 [No Abstract] [Full Text] [Related]
38. Targets of protective tumor immunity. Dranoff G Ann N Y Acad Sci; 2009 Sep; 1174():74-80. PubMed ID: 19769739 [TBL] [Abstract][Full Text] [Related]